Endocrine cells in the human oxyntic mucosa. A histochemical study.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 2470131)

Published in Scand J Gastroenterol on November 01, 1988

Authors

M Simonsson1, S Eriksson, R Håkanson, T Lind, H Lönroth, L Lundell, D T O'Connor, F Sundler

Author Affiliations

1: Dept. of Medical Cell Research, University of Lund, Sweden.

Articles citing this

Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci (2011) 1.43

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc Natl Acad Sci U S A (1996) 1.25

Structure and physiological actions of ghrelin. Scientifica (Cairo) (2013) 1.06

Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer (2006) 1.05

Histamine containing endocrine cells in the human stomach. Gut (1990) 1.04

Physiological significance of ECL-cell histamine. Yale J Biol Med (1999) 0.92

Cell lineage distribution atlas of the human stomach reveals heterogeneous gland populations in the gastric antrum. Gut (2014) 0.90

Relationship of ECL cells and gastric neoplasia. Yale J Biol Med (1999) 0.87

Somatostatin-receptor 2 (sst2)-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach. Br J Pharmacol (2005) 0.85

The biology and pathobiology of the ECL cells. Yale J Biol Med (1994) 0.84

Mapping analysis of ghrelin producing cells in the human stomach associated with chronic gastritis and early cancers. Dig Dis Sci (2011) 0.82

Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours. Ann R Coll Surg Engl (1996) 0.81

The pathobiology of the human enterochromaffin-like cell. Yale J Biol Med (1994) 0.79

Chromogranin A in gastric neuroendocrine tumours: an immunohistochemical and biochemical study with region-specific antibodies. Virchows Arch (2006) 0.78

Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas. World J Surg (2004) 0.78

Gastric epithelial cell modality and proton pump inhibitor. J Clin Biochem Nutr (2008) 0.78

Endocrine cells in human fetal corpus of stomach: appearance, distribution, and density. J Gastroenterol (2012) 0.76

Intestinal endocrine cells in Hirschsprung's disease. No reduction in density in aganglionic compared with ganglionic segment. Int J Colorectal Dis (1990) 0.75

Ontogeny of ECL cells in the rat. Yale J Biol Med (1999) 0.75

Articles by these authors

The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology (1996) 4.69

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med (1996) 4.11

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man. Gut (1983) 3.46

Mammalian deoxyribonucleoside kinases. Pharmacol Ther (1995) 3.31

Myrosinase: gene family evolution and herbivore defense in Brassicaceae. Plant Mol Biol (2000) 3.15

The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol (1998) 3.04

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03

Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet (2001) 2.91

Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med (1986) 2.84

Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut (1996) 2.79

Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl (1965) 2.77

Randomized clinical trial of open versus laparoscopic cholecystectomy in the treatment of acute cholecystitis. Br J Surg (2005) 2.75

The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet (2001) 2.71

Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun (1998) 2.71

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia. Neurology (1999) 2.51

Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut (2004) 2.48

Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J Biol Chem (1985) 2.47

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46

Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci U S A (1976) 2.45

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother (2001) 2.35

Collagenous colitis and fecal stream diversion. Gastroenterology (1995) 2.32

Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept (1984) 2.27

Oral immunoglobulin A supplement in treatment of Clostridium difficile enteritis. Lancet (1993) 2.22

The transfer of basic skills learned in a laparoscopic simulator to the operating room. Surg Endosc (2002) 2.21

Cell cycle-dependent regulation of mammalian ribonucleotide reductase. The S phase-correlated increase in subunit M2 is regulated by de novo protein synthesis. J Biol Chem (1984) 2.19

Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J Biol Chem (1991) 2.19

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol (1988) 2.17

Randomized clinical trial of day-care versus overnight-stay laparoscopic cholecystectomy. Br J Surg (2006) 2.15

Bacterial genome size reduction by experimental evolution. Proc Natl Acad Sci U S A (2005) 2.13

Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor. Eur J Neurosci (2000) 2.12

Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther (2009) 2.11

Long-term results of a prospective randomized comparison of total fundic wrap (Nissen-Rossetti) or semifundoplication (Toupet) for gastro-oesophageal reflux. Br J Surg (1996) 2.11

Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol (1994) 2.07

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study. Antimicrob Agents Chemother (1999) 2.07

Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept (1986) 2.05

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol (1997) 2.02

Magnetic resonance imaging pelvimetry: a useful adjunct in the management of the obese patient. Br J Obstet Gynaecol (1992) 2.02

Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J (2001) 1.97

The liver in adolescents with alpha 1-antitrypsin deficiency. Hepatology (1995) 1.95

Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut (2008) 1.93

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91

Ribonucleotide reductase from calf thymus. Purification and properties. Biochemistry (1979) 1.90

Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology (1983) 1.90

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest (1997) 1.86

Trapped antihydrogen. Nature (2010) 1.85

Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J Exp Med (1997) 1.84

The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept (2002) 1.82

Systematic review: microscopic colitis. Aliment Pharmacol Ther (2006) 1.81

On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis--a placebo-controlled randomized trial. Aliment Pharmacol Ther (1999) 1.80

Ribonucleotide reductase from calf thymus. Separation of the enzyme into two nonidentical subunits, proteins M1 and M2. J Biol Chem (1980) 1.78

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76

A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature (1981) 1.76

Allosteric regulation of calf thymus ribonucleoside diphosphate reductase. Biochemistry (1979) 1.76

Liver disease in adults with alpha-1 -antitrypsin deficiency. N Engl J Med (1972) 1.75

Endothelial cells are a site of uptake and degradation of hyaluronic acid in the liver. Exp Cell Res (1983) 1.74

Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol (1999) 1.74

Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia (1976) 1.74

Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg (2010) 1.71

Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71

Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71

The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut (2001) 1.70

Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans. Gastroenterology (1982) 1.66

Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut (1995) 1.64

The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Aliment Pharmacol Ther (2004) 1.64

Familial occurrence of microscopic colitis: a report on five families. Scand J Gastroenterol (2001) 1.64

The comet assay: mechanisms and technical considerations. Mutat Res (1996) 1.62

Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet (1991) 1.60

Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med (1986) 1.58

Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry (1986) 1.57

Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57

Management of acute cholecystitis in the laparoscopic era: results of a prospective, randomized clinical trial. J Gastrointest Surg (2003) 1.56

Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry (1996) 1.56

Carcinoma and possible precancerous changes of the gastric stump after billroth II resection. Gastroenterology (1977) 1.56

Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer (1984) 1.56

Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut (2004) 1.56

Liver, lung and malignant disease in heterozygous (Pi MZ) alpha1-antitrypsin deficiency. Acta Med Scand (1975) 1.55

Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol (1979) 1.54

The epidemiology of shoulder dislocations. Arch Orthop Trauma Surg (1989) 1.53

Maternal body mass index in early pregnancy and offspring asthma, rhinitis and eczema up to 16 years of age. Clin Exp Allergy (2015) 1.53

Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52

Ribonucleoside diphosphate reductase from Escherichia coli. An immunological assay and a novel purification from an overproducing strain lysogenic for phage lambdadnrd. J Biol Chem (1977) 1.52

Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol (2001) 1.51

Genetic influences on endometriosis in an Australian twin sample. sueT@qimr.edu.au. Fertil Steril (1999) 1.51

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies. Aliment Pharmacol Ther (2015) 1.51

A nationwide study of the use of self-expanding stents in patients with esophageal cancer in Sweden. Endoscopy (2005) 1.51

Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers. Gut (1989) 1.50

Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension (2000) 1.50

Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver endothelial cells. Biochem J (1984) 1.50